Published in Women's Health Weekly, March 17th, 2005
Sales for the second quarter of fiscal year 2005 were $6,145,254, an increase of $5,838,712 over the prior year quarter.
On a pro forma basis, sales for the quarter ending Dec. 31, 2004, increased about 25% or approximately $1,232,000 over the comparable prior year quarter. Excluding the beneficial impact of foreign exchange rates, this growth was approximately 20%. Pro forma results are shown because MediCor's results include the substantial benefit from the acquisition of Eurosilicone S.A. on July 5, 2004, which was not part of MediCor's results in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.